1/18/23 16:19 | 1/17/23 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Pasternak Andy | L2 | O | EVP,Chie | S | -3,066 | 113.03 | 0 | -27 | -33 | 56 | D | | | | | | | | | | | | | | |
1/4/23 16:14 | 12/30/22 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Pasternak Andy | L2 | O | EVP,Chie | M.d | 0 | 0.00 | 0 | 89 | | 83 | D | | | | | | | | | | | | | | |
12/14/22 17:10 | 12/13/22 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Pasternak Andy | L2 | O | EVP,Chie | M.d | 686 | 29.52 | 0 | 23 | 215 | 34 | D | | | | | | | | | | | | | | |
12/14/22 17:10 | 12/13/22 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Pasternak Andy | L2 | O | EVP,Chie | S.d | -3,397 | 112.61 | 0 | -30 | -47 | 34 | D | | | | | | | | | | | | | | |
11/2/22 16:12 | 11/1/22 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Pasternak Andy | L2 | O | EVP,Chie | M.d | 0 | 0.00 | 0 | 12 | 44 | 41 | D | | | | | | | | | | | | | | |
7/29/22 17:21 | 7/29/22 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Pasternak Andy | L2 | O | EVP,Chie | S | -400 | 82.57 | 0 | -5 | -12 | 34 | D | | | | | | | | | | | | | | |
6/13/22 16:19 | 6/10/22 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Pasternak Andy | L2 | O | EVP,Chie | S | -65 | 85.36 | 0 | -1 | -2 | 39 | D | | | | | | | | | | | | | | |
2/18/22 16:42 | 2/18/22 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Pasternak Andy | L2 | O | EVP,Chie | S | -124 | 94.82 | 0 | -1 | -3 | 40 | D | | | | | | | | | | | | | | |
1/6/22 21:02 | 1/5/22 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Pasternak Andy | L2 | O | EVP,Chie | M.d | 0 | 0.00 | 0 | 49 | | 41 | D | | | | | | | | | | | | | | |
1/6/22 21:02 | 1/6/22 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Pasternak Andy | L2 | O | EVP,Chie | S.d | -795 | 99.57 | 0 | -8 | -16 | 41 | D | | | | | | | | | | | | | | |
12/8/21 18:35 | 12/7/21 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Pasternak Andy | L2 | O | EVP,Chie | S | -153 | 100.00 | 0 | -2 | -7 | 22 | D | | | | | | | | | | | | | | |
11/5/21 17:00 | 11/4/21 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Pasternak Andy | L2 | O | EVP,Chie | M.d | 686 | 29.52 | 0 | 23 | 999% | 23 | D | | | | | | | | | | | | | | |
11/5/21 17:00 | 11/4/21 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Pasternak Andy | L2 | O | EVP,Chie | S.d | -3,410 | 113.04 | 0 | -30 | -56 | 23 | D | | | | | | | | | | | | | | |
11/3/21 16:31 | 11/1/21 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Pasternak Andy | L2 | O | EVP,Chie | M.d | 0 | 0.00 | 0 | 12 | 70 | 30 | D | | | | | | | | | | | | | | |
9/13/21 20:00 | 9/9/21 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Pasternak Andy | L2 | O | EVP,Chie | M.d | 686 | 29.52 | 0 | 23 | 999% | 23 | D | | | | | | | | | | | | | | |
9/13/21 20:00 | 9/9/21 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Pasternak Andy | L2 | O | EVP,Chie | S.d | -2,507 | 107.84 | 0 | -23 | -50 | 23 | D | | | | | | | | | | | | | | |
1/6/21 21:14 | 1/5/21 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Pasternak Andy | L2 | O | EVP,Chie | M.d | 0 | 0.00 | 0 | 15 | 757 | 16 | D | | | | | | | | | | | | | | |
11/3/20 16:25 | 11/1/20 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Pasternak Andy | L2 | O | EVP,Chie | M.d | 0 | 0.00 | 0 | 12 | | 8 | D | | | | | | | | | | | | | | |